Ellen Louise Swan
Honeywell
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ellen Louise Swan.
Aiha Journal | 2003
Raymond Boucher; Constance Hanna; George M. Rusch; Danny Stidham; Ellen Louise Swan; Manny Vazquez
1,1-Dichloro-2,2,2-trifluoroethane (HCFC-123) was evaluated as a substitute for trichlorofluoromethane (CFC-11), and it appeared that a permissible exposure limit of 50 ppm was justified. When HCFC-123 was introduced as a precision cleaning agent in a controlled operation, marked elevations in serum alanine transaminase and serum aspartase transaminase were noted in exposed workers. Sampling taken during start-up documented personal samples from 24-480 ppm (375 and 21 min, respectively) and area samples of 18-180 ppm (375 and 21 min, respectively). Personal and area samples collected after the liver abnormalities were identified ranged from 5-12 ppm. Exposure data were not available for the period when the abnormalities are suspected to have developed. Two models were developed to estimate exposure during the unmonitored period: (1) the entire plant as a homogenous box and (2) evaporation into smaller work zones. Modeling using the entire building estimated 8-hour time-weighted average (TWA) exposures of 10-35 ppm. Modeled estimates of work area and air exchange rates indicated that degreaser exposed workers could have experienced peak levels of 280-2,100 ppm (8-hour TWAs 252-1,630 ppm). Modeling of the work environment, estimated to be one-third of the volume of the entire open building, indicated peak exposures of 28-210 ppm (8-hour TWAs 25-163 ppm). These ranges estimate the minimum and maximum exposure levels. The best estimates, using 12 air changes per day, suggest peak levels around the degreaser of 635-2,100 ppm (8-hour TWA 499-1,630 ppm) and 63-207 ppm (8-hour TWAs 50-163 ppm) in the work area. These are the first estimates of exposure level associated with these hepatotoxic effects; all are significantly higher than personal and area samples collected for HCFC-123 after the liver abnormalities were identified.
Archive | 1999
Russell F. Anderson; David E. Bradley; David Nalewajek; Haridasan K. Nair; Mariola Jolanta Proszowski; Eugene V. Sitzman; Ellen Louise Swan
Archive | 2004
Nancy Iwamoto; William Bedwell; David Nalewajek; Sean Curran; Thomas Williams; Denis H. Endisch; Alan Levy; Ellen Louise Swan
Archive | 1993
Ellen Louise Swan; Rajat Subhra Basu
Archive | 1991
Ellen Louise Swan; Peter Brian Logsdon; Leonard M. Stachura; Rajat Subhra Basu
Archive | 1990
Ellen Louise Swan; Rajat Subhra Basu; Ian Robert Shankland
Archive | 1990
Ellen Louise Swan; Peter Brian Logsdon; Leonard M. Stachura; Rajat Subhra Basu
Archive | 1999
Russell F. Anderson; David E. Bradley; Nair K. Haridasan; David Nalewajek; Mariola Jolanta Proszowski; Eugene Valentine Sitzmann; Ellen Louise Swan
Archive | 1997
Earl August Eugene Lund; Hang Thanh Pham; Ian Shankland; Ellen Louise Swan
Archive | 1994
David Nalewajek; Rajat Subhra Basu; David P. Wilson; Der Puy Michael Van; Ellen Louise Swan; Peter Brian Logsdon; Gary John Zyhowski; Hepburn Ingham; Daniel Franklin Harnish; Joel Edward Rodgers